2 weeks Ago By ABMN Staff
Alethea Capital Management LLC acquired a new stake in The Clorox Company ( NYSE:CLX – Free Report ) during the 2nd quarter, HoldingsChannel.com reports. The fund acquired 1,875 shares of the company’s stock, valued at approximately $256,000.
Clorox comprises approximately 0.2% of Alethea Capital Management LLC’s investment portfolio, making the stock its 27th biggest holding. A number of other hedge funds and other institutional investors have also recently bought and sold shares of CLX.
Core Wealth Advisors Inc. acquired a new stake in Clorox in the 4th quarter valued at about $29,000. Innealta Capital LLC purchased a new stake in shares of Clorox during the second quarter worth approximately $30,000.
Trifecta Capital Advisors LLC increased its stake in shares of Clorox by 139.8% during the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares during the period.
GoalVest Advisory LLC acquired a new stake in Clorox in the first quarter valued at approximately $31,000. Finally, First Foundation Advisors purchased a new position in Clorox in the first quarter worth approximately $31,000. 78.
53% of the stock is currently owned by hedge funds and other institutional investors. Wall Street Analyst Weigh In A number of brokerages have recently weighed in on CLX. Barclays raised their price objective on shares of Clorox from $122.
00 to $130.00 and gave the company an “underweight” rating in a report on Monday, August 5th. TD Cowen assumed coverage on Clorox in a report on Tuesday, July 23rd.
They set a “sell” rating and a $122.00 price target for the company. Deutsche Bank Aktiengesellschaft increased their price objective on Clorox from $144.
00 to $151.00 and gave the company a “hold” rating in a report on Friday, August 2nd. Argus upgraded Clorox to a “hold” rating in a research note on Tuesday, June 4th.
Finally, DA Davidson reissued a “neutral” rating and set a $153.00 price objective on shares of Clorox in a report on Friday, September 6th. Six analysts have rated the stock with a sell rating and twelve have assigned a hold rating to the company’s stock.
According to MarketBeat.com, Clorox has an average rating of “Hold” and a consensus price target of $143.33.
Clorox Price Performance Shares of NYSE:CLX opened at $163.43 on Friday. The Clorox Company has a one year low of $114.
68 and a one year high of $169.09. The stock has a market capitalization of $20.
30 billion, a price-to-earnings ratio of 84.68, a PEG ratio of 3.31 and a beta of 0.
40. The company has a 50-day simple moving average of $151.35 and a 200-day simple moving average of $144.
09. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.
63 and a current ratio of 1.03. Clorox ( NYSE:CLX – Get Free Report ) last posted its quarterly earnings data on Thursday, August 1st.
The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.
28. Clorox had a return on equity of 281.12% and a net margin of 3.
95%. The company had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.
97 billion. On average, analysts predict that The Clorox Company will post 6.63 EPS for the current year.
Clorox Announces Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be issued a $1.22 dividend.
This represents a $4.88 dividend on an annualized basis and a yield of 2.99%.
The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio is presently 252.85%.
Insiders Place Their Bets In related news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.
52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.
92. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link . 0.
51% of the stock is currently owned by insiders. Clorox Company Profile ( Free Report ) The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International.
The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. Recommended Stories Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company ( NYSE:CLX – Free Report ).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter ..
